We are live on ! Find out more
PAHC icon

Phibro Animal Health

149 hedge funds and large institutions have $265M invested in Phibro Animal Health in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

1% more funds holding

Funds holding: 148149 (+1)

2% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 54

3.63% less ownership

Funds ownership: 101.62%97.99% (-3.6%)

33% less capital invested

Capital invested by funds: $395M → $265M (-$130M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $199K

Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
2.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
53
Reduced
54
Closed
21
Calls
Puts
$199K
Net Calls
-$199K
Net Calls Change
-$199K
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
101
Shell Asset Management
Netherlands
$138K -$46.8K -2,713 -21%
CIS
102
Connors Investor Services
Pennsylvania
$133K
AB
103
Amalgamated Bank
New York
$131K -$725 -42 -0.4%
Deutsche Bank
104
Deutsche Bank
Germany
$127K -$22.4K -1,299 -12%
State of Tennessee, Department of Treasury
105
State of Tennessee, Department of Treasury
Tennessee
$107K +$6.37K +369 +5%
OPERF
106
Oregon Public Employees Retirement Fund
Oregon
$89K +$5.08K +294 +5%
New York State Teachers Retirement System (NYSTRS)
107
New York State Teachers Retirement System (NYSTRS)
New York
$86K
Lazard Asset Management
108
Lazard Asset Management
New York
$85K
TRCT
109
Tower Research Capital (TRC)
New York
$71K +$75.3K +4,364 +430%
TRSOTSOK
110
Teachers Retirement System of the State of Kentucky
Kentucky
$71K +$92.2K +5,339 New
UBS Group
111
UBS Group
Switzerland
$59K +$75K +4,345 +3,714%
Federated Hermes
112
Federated Hermes
Pennsylvania
$56K -$81K -4,689 -53%
Zurich Cantonal Bank
113
Zurich Cantonal Bank
Switzerland
$55K
MOACM
114
Mutual of America Capital Management
New York
$54K +$10.9K +631 +18%
US Bancorp
115
US Bancorp
Minnesota
$35K -$146K -8,447 -76%
GCM
116
Gladius Capital Management
Illinois
$33K -$19K -1,099 -31%
Fidelity Investments
117
Fidelity Investments
Massachusetts
$27K +$24.4K +1,413 +217%
Macquarie Group
118
Macquarie Group
Australia
$21K -$9.31K -539 -34%
AIP
119
Ameritas Investment Partners
Nebraska
$21K
KBC Group
120
KBC Group
Belgium
$21K
PNC Financial Services Group
121
PNC Financial Services Group
Pennsylvania
$18K +$8.74K +506 +65%
MLICM
122
Metropolitan Life Insurance Company (MetLife)
New York
$17.9K
Carson Wealth (CWM LLC)
123
Carson Wealth (CWM LLC)
Nebraska
$14K +$17.9K +1,037 +2,729%
QT
124
Quantbot Technologies
New York
$11K +$15.5K +900 New
IA
125
IFP Advisors
Florida
$10K +$483 +28 +22%

PAHC Hedge Fund Activity: Q3 2022 in Review

149 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2022, worth a combined $265M — down 33% from $395M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PAHC positions and 21 closed out — a net gain of 3 holders — while 53 added to existing stakes and 54 trimmed.

The largest buyer was Millennium Management, adding an estimated $10.8M. The largest seller was Fiduciary Management Inc, exiting entirely with an estimated $17M sold.

  • 149 institutional investors held Phibro Animal Health (PAHC) as of Q3 2022, up from 148 in Q2 2022.
  • Funds reported $265M of Phibro Animal Health stock for Q3 2022, down 33% quarter-over-quarter.
  • 24 funds opened new Phibro Animal Health positions in Q3 2022 and 21 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q3 2022 was Millennium Management, an estimated $10.8M added.
  • The largest Phibro Animal Health seller in Q3 2022 was Fiduciary Management Inc, an estimated $17M sold.

Based on aggregated 13F filings for Q3 2022.